ASTRO announces 2006 Gold Med...( ASTRO where he served as both presiden...),Health

ASTRO, where he served as both president and chair of the Board of Directors. The impact of these policies ensures that the field of radiation oncology is continuously renewed and advanced by each successive generation. He has also served in leadership roles with the American College of Radiology, the American Radium Society and the Society of Chairs of Academic Radiation Oncology Programs. Dr. Hoppe is also a member of the National Cancer Institute Board of Scientific Counselors and the Board of Directors of Stanford Hospital and Clinics.

Hailed as the leading medical physicist in the United States, Dr. Ling is world renown as a top authority in developing and implementing advanced treatment planning and delivery systems and has made significant contributions to the establishment of conformal radiotherapy as a state-of-the-art curative treatment for human cancer. He and his colleagues have spear-headed the technological developments of intensity modulated radiation therapy in the treatment of prostate and other cancers, thus cementing Memorial Sloan-Kettering Cancer Center as a cutting-edge leader in the field. Dr. Ling is also recognized as a pioneer in the development of image-based radiotherapy. His numerous papers and presentations on this topic have led to the widespread interest in this field. Dr. Ling has been an active researcher for thirty years, with numerous grant awards from NCI, ACS, DOE, DOD and others. He has been an important leader in medical physics in some of the premier institutions in the world, including the George Washington University, the University of California in San Francisco and Memorial Sloan-Kettering and has been influential in the development of many professional and research careers. At Memorial Sloan Kettering, he succeeded the late Gioacchino Failla and John Laughlin as Chair of the Medical Physics Department. Dr. Ling has been active in numerous scientific and medical associations including ASTRO, the American Associat
'"/>

Contact: Beth Bukata
bethb@astro.org
703-839-7332
American Society for Therapeutic Radiology and Oncology
29-Jun-2006

Page: 1 2 3
Related medicine news :

1. ASTRO awards $240,000 to four cancer researchers
2. ASTRO annual meeting again named a fastest growing tradeshow
3. Three cancer researchers win awards from ASTRO
4. October 17 news briefing highlights groundbreaking cancer studies at ASTRO Annual Meeting
5. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
6. AstraZeneca announces SYMBICORT is now available in the US
7. Weill Cornell Medical College announces gifts totaling $400M
8. GSK announces launch of largest ever Phase III trial in lung cancer treatment
9. Elsevier announces launch of Brain Stimulation
10. NSW Premier announces $15M for childrens cancer research
11. National Inventors Hall of Fame announces 2007 inductees